Physician profile
Bryan J Young
NPI 1851452452
$1,598.37
in general payments reported to CMS, 2019-2025
17 companies · $44.58 in 2025
The $44.58 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $513 · 2020: $141 · 2021: $218 · 2022: $244 · 2023: $182 · 2024: $256 · 2025: $44.58.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $468 · Education: $14.52.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $468.36 |
| Education | $14.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $225.33 | 2021-2024 | Vraylar |
| Bayer Healthcare Pharmaceuticals INC. | $207.23 | 2023-2025 | |
| Amarin Pharma, INC. | $129.40 | 2020 | |
| Lilly USA, LLC | $128.24 | 2021-2022 | |
| Amgen INC. | $125.95 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $123.88 | 2019 | |
| Pfizer INC. | $122.08 | 2024 | |
| Sanofi-Aventis U.S. LLC | $119.95 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $88.69 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $87.90 | 2019 | |
| Esperion Therapeutics, INC. | $83.53 | 2021 | |
| Therapeuticsmd, INC. | $66.90 | 2019 | |
| Sumitomo Pharma America, INC. | $29.48 | 2023 | Gemtesa |
| Abbott Laboratories | $15.72 | 2025 | Freestyle Libre 3 |
| Glaxosmithkline, LLC. | $15.33 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Radius Health, INC. | $14.52 | 2023 | |
| Exact Sciences Corporation | $14.24 | 2025 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Young listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.